Clinical Trials Browser

Phase 1 × Kidney Diseases × Gynecologic × Clear all

NCT02837991 2020-06-04

A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma

Phase 1 Terminated

GenitourinaryGynecologic

Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Ovarian Neoplasms